Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-73
Closed -$18K – 44
2021
Q1
$18K Hold
73
– – 0.01% 46
2020
Q4
$17K Hold
73
– – 0.01% 54
2020
Q3
$17K Hold
73
– – 0.01% 47
2020
Q2
$17K Sell
73
-135
-65% -$30.8K 0.01% 47
2020
Q1
$42K Hold
208
– – 0.02% 57
2019
Q4
$50K Sell
208
-19
-8% -$4.19K 0.02% 60
2019
Q3
$44K Hold
227
– – 0.02% 71
2019
Q2
$42K Buy
+227
New +$40.6K 0.02% 75
2017
Q1
– Sell
-4,510
Closed -$659K – 53
2016
Q4
$659K Hold
4,510
– – 0.28% 64
2016
Q3
$752K Buy
+4,510
New +$763K 0.34% 65

Other funds holding AMGN

Ashburton (Jersey)'s AMGN Position: Q2 2021 in Review

Ashburton (Jersey) sold out of Amgen (AMGN) in Q2 2021, closing a stake of 73 shares — an estimated $18K sold.

Ashburton (Jersey) first reported a position in AMGN in Q3 2016 and held it in 10 quarters. The position peaked at $752K in Q3 2016. 2,197 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • Ashburton (Jersey) reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
  • Ashburton (Jersey) sold 73 Amgen shares in Q2 2021, an estimated $18K.
  • Ashburton (Jersey) first reported a position in Amgen in Q3 2016 and held it in 10 quarters.
  • Ashburton (Jersey)'s Amgen position peaked at $752K in Q3 2016.
  • 2,197 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Ashburton (Jersey)'s 13F filing for Q2 2021, filed 26 May 2023.